Ganesan Laboratory - News

February 9, 2021

A George Mason University and Rutgers Cancer Institute of New Jersey collaboration received the U.S. Army’s Breast Cancer Research Program (BCRP) Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized breast cancer treatments. Read more


August 5, 2019

Rutgers Cancer Institute physician-scientists Shridar Ganesan, MD, PhD, and Andrew M. Evens, DO, MSc, FACP, are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program. Learn more